Alnylam Japan K.K. is the Japanese entity of Alnylam Pharmaceuticals, the leading RNA interference (RNAi) therapeutics company developing medicines for rare and prevalent diseases.
No hay comentarios disponibles.
Deja tu valoración & comentario